Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Genus Stock

Genus Stock GNS.L

GNS.L
GB0002074580
762548

Price

0
Today +/-
-0
Today %
-0 %

Genus stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Genus stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Genus stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Genus stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Genus's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Genus Stock Price History

DateGenus Price
8/8/20250 undefined
8/8/202525.10 undefined
8/7/202525.10 undefined
8/6/202524.95 undefined
8/5/202525.15 undefined
8/4/202525.25 undefined
8/1/202524.90 undefined
7/31/202524.95 undefined
7/30/202524.80 undefined
7/29/202525.10 undefined
7/28/202524.75 undefined
7/25/202524.65 undefined
7/24/202524.50 undefined
7/23/202524.00 undefined
7/22/202524.15 undefined
7/21/202524.20 undefined
7/18/202524.15 undefined
7/17/202524.45 undefined
7/16/202524.05 undefined
7/15/202524.05 undefined
7/14/202522.20 undefined
7/11/202522.10 undefined

Genus Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Genus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Genus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Genus’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Genus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Genus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Genus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Genus’s growth potential.

Genus Revenue, EBIT and net profit per share

DateGenus RevenueGenus EBITGenus Net Income
2029e753.71 M undefined126.82 M undefined89.74 M undefined
2028e805.69 M undefined102.1 M undefined84.29 M undefined
2027e754.59 M undefined100.22 M undefined68.7 M undefined
2026e720.67 M undefined90.37 M undefined60.71 M undefined
2025e693.62 M undefined79.19 M undefined52.15 M undefined
2024668.8 M undefined54.2 M undefined7.9 M undefined
2023689.7 M undefined60.9 M undefined33.3 M undefined
2022593.4 M undefined56.8 M undefined40.9 M undefined
2021574.3 M undefined61.8 M undefined47.3 M undefined
2020551.4 M undefined45.8 M undefined35.3 M undefined
2019488.5 M undefined46.4 M undefined7.8 M undefined
2018470.3 M undefined42.8 M undefined42.7 M undefined
2017459.1 M undefined41.8 M undefined32.8 M undefined
2016388.3 M undefined39.4 M undefined49.3 M undefined
2015398.5 M undefined39.7 M undefined39.9 M undefined
2014372.2 M undefined43.8 M undefined28.9 M undefined
2013345.3 M undefined37.9 M undefined27 M undefined
2012341.8 M undefined17.4 M undefined39.5 M undefined
2011309.9 M undefined33.8 M undefined29.2 M undefined
2010285.3 M undefined33.2 M undefined27.5 M undefined
2009280.4 M undefined33 M undefined17.9 M undefined
2008247.1 M undefined24.8 M undefined17.7 M undefined
2007233.8 M undefined22.2 M undefined14.6 M undefined
2006287.2 M undefined13.8 M undefined-300,000 undefined
2005183.2 M undefined9.6 M undefined6.4 M undefined

Genus Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
464757133162160172183183287233247280285309341345372398388459470488551574593689668693720754805753
-2.1721.28133.3321.80-1.237.506.40-56.83-18.826.0113.361.798.4210.361.177.836.99-2.5118.302.403.8312.914.173.3116.19-3.053.743.904.726.76-6.46
21.7423.4026.3224.8143.2145.0038.9538.8040.987.6712.0212.9656.4363.1659.2258.3635.0734.6833.4237.3735.9537.4536.6832.4931.1830.1925.9826.8025.8324.8623.7422.2423.77
1011153370726771752228321581801831991211291331451651761790000000000
433310256014171727293927283949324273547403375260688489
--25.00---66.67--150.0020.00--21.43-58.827.4134.48-30.773.7039.2925.64-34.6931.25-83.33400.0034.29-14.89-17.50-78.79642.8615.3813.3323.535.95
--------------------------0.960.960.960.450.510.630.67
00000000000000000000000000000-53.1313.3323.536.35
232328.427.932.933.234.234.536.845.356.558.659.960.260.660.96160.761.4861.3961.8362.1265.365.4365.6665.46666.1700000
---------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Genus Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Genus is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (B)
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                       
10.41110.22.45.12.76.84.37.622.92619.320.618.114.214.218.422.821.33426.529.130.541.34638.836.342.5
7.47.811.326.525.124.42726.128.838.234.742.146.152.456.256.863.663.464.46573.79198100.889.9108.7113.9115.2
0.20.91.41.31.21.91.41.11.95.57.796.86.97.37.611.88.27.48.89.21.43.33.112.316.314.512.5
2.82.52.214.514.214.717.616.217.420.618.821.82831.133.530.234.974.782.4102.176.934.23637.476.68485.189.4
0.50.72.44.44.33.23.85.26.210.949.226.430.239.134.244.444.74.74.56.29.439.741.441.26.99.79.211.5
21.322.927.549.149.946.956.652.961.998.1136.4118.6131.7147.6145.4153.2173.4173.8180216.1195.7195.4209.2223.8231.7257.5259271.1
15.115.615.82018.916.616.915.916.735.1141.4154.6193.2218.9227.8264.7269249.5293326.4376.8362.2373.1428402.9505.1482.6479.4
000.20.71.80.10.10.20.33455.67.78.79.311.521.819.827.928.225.83129.648.851.462.361.6
000000000000000000000001.81.88.68.211.8
0.20.20.2000000.10.277.479.581.181.575.671.268.364.469.87888.378.77262.956.37266.265.4
003.833.533.331.328.125.925.9174.360.76370.568.468.366.467.869.973.986104.7102106.3105.6101.5111107.8110.3
000000000014.915.318.418.315.623.420.44.87.84.73.94.63.93.7812.321.429.3
15.315.82054.2544845.14243212.6298.4317.4368.8394.8396435437410.4464.3523601.9573.3586.3631.6619.3760.4748.5757.8
0.040.040.050.10.10.090.10.090.10.310.430.440.50.540.540.590.610.580.640.740.80.770.80.860.851.021.011.03
                                                       
2.32.32.53.13.33.33.43.53.75.55.65.966666.16.16.16.16.16.26.56.56.66.66.66.6
20.720.722.331.733.934.134.73739.992.292.5111.7111.7112112112.1112.1112.2112.2112.3112.8112.8179179.1179.1179.1179.1179.1
4.54.478.911.110.99.48.211.53.969.374.878104.5129.8140.6156.9178.6202.7219.3240.2260258.9280.7320.4340.6360.6351.2
0000000000-16.3-7.2929.123.916.625.1-12.1-10.136.940.322.53628.3-7.952.328.711.4
0000000000000000000000000000
27.527.431.843.748.348.347.548.755.1101.6151.1185.2204.7251.6271.7275.3300.2284.8310.9374.6399.4401.5480.4494.6498.2578.6575548.3
2.22.12.915.715.614.619.416.318.915.112.315.111.913.112.914.918.116.858.920.720.783.787.79523.73634.8157.2
4.24.35.18.78.68.2108.97.823.33.44.93.14.55.65.94.64.804.46.70008.297.77.3
1.325.35.34.94.74.88.77.110.733.628.52940.834.934.337.642.18.946.657.526.812.21687.789.190.590.4
0003.45.92.45.96.2130000000000000000000
0.51.21.413.68.47.77.64.91.814.528.118.63.42.54.99.18.714.113.35.79.114.84.319.222.917.214.218.9
8.29.614.746.743.437.647.74548.663.677.467.147.460.958.364.26977.881.177.494125.3104.2130.2142.5151.3147.2273.8
0.71.30.712.711.285.50.60.3125.3110.378.2105.295.681.365.962.672.679.8118129122.8105.8124.7128.7206.6217.9272.3
000.10.110.70.60.70.96.57880.496.3103.6104.9113.5113.190.3105.2118.5124.269.566.765.55360.351.244.4
0.30.30.10.1000.30013.918.225.24730.5256965.258.273.157.148.347.239.840.530.227.62417.7
11.60.912.912.28.76.41.31.2145.7206.5183.8248.5229.7211.2248.4240.9221.1258.1293.6301.5239.5212.3230.7211.9294.5293.1334.4
9.211.215.659.655.646.354.146.349.8209.3283.9250.9295.9290.6269.5312.6309.9298.9339.2371395.5364.8316.5360.9354.4445.8440.3608.2
0.040.040.050.10.10.090.10.10.10.310.430.440.50.540.540.590.610.580.650.750.790.770.80.860.851.021.021.16
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Genus provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Genus's financial health and stability.

Assets

Genus's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Genus must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Genus after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Genus's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (k)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
1135678898141717272939272840503441635463631
3334655551498101110101111131420242637353943
000000000000000000000000000
1,000-1,00000-2,000-4,000-2,000-3,000-9,000-17,000-7,000-11,000-21,000-18,000-12,000-12,000-20,000-7,000-11,000-12,000-13,000-15,000-20,000-13,000-13,000-44,000-40,000
-100000000365761-560-7-23-6-72010315
00012111101086332112133343511
000221122435676889121110111213161717
4469981010582320142628322432343034433360673450
-4-4-5-3-3-3-6-3-4-11-7-8-15-8-4-8-8-6-14-18-18-22-28-29-33-65-35
-8-1-4-46-4-1-6-3-6-17219-12-7-2-7-6-39-23-19-39-20-46-25-46-67-30
-420-420100-1-16081830211-32-8-1-201-174-12-14
000000000000000000000000000
01021-6-3-2-7-3120-15-423-16-9-14-823-21410-4-36-47434
000920023540190000000000660000
00-129-6-5-3-6-2174-30-37-2-22-25-24-1713-130-3-1913-23-1421-18
-----------10.00-8.00---8.00-----1.00-----2.00--1.00
0000-1-1-1-1-20-4-5-5-6-7-10-9-10-11-12-13-14-16-18-19-20-21
-230-60100-311-6-81-20004-112-721104-7-2
0.670.350.676.016.055.234.516.550.62-2.4516.711.3-1.418.523.323.715.425.72011.415.720.75.130.433.7-31.115.2
000000000000000000000000000

Genus stock margins

The Genus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genus.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Genus's sales revenue. A higher gross margin percentage indicates that the Genus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Genus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Genus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Genus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Genus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Genus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Genus Margin History

Genus Gross marginGenus Profit marginGenus EBIT marginGenus Profit margin
2029e36.68 %16.83 %11.91 %
2028e36.68 %12.67 %10.46 %
2027e36.68 %13.28 %9.1 %
2026e36.68 %12.54 %8.42 %
2025e36.68 %11.42 %7.52 %
202436.68 %8.1 %1.18 %
202336.68 %8.83 %4.83 %
202236.68 %9.57 %6.89 %
202136.68 %10.76 %8.24 %
202036.68 %8.31 %6.4 %
201936.68 %9.5 %1.6 %
201837.47 %9.1 %9.08 %
201735.98 %9.1 %7.14 %
201637.57 %10.15 %12.7 %
201533.43 %9.96 %10.01 %
201434.74 %11.77 %7.76 %
201335.19 %10.98 %7.82 %
201258.34 %5.09 %11.56 %
201159.24 %10.91 %9.42 %
201063.09 %11.64 %9.64 %
200956.53 %11.77 %6.38 %
200813.11 %10.04 %7.16 %
200712.28 %9.5 %6.24 %
20067.87 %4.81 %-0.1 %
200541.21 %5.24 %3.49 %

Genus Stock Sales Revenue, EBIT, Earnings per Share

The Genus earnings per share therefore indicates how much revenue Genus has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Genus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Genus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Genus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Genus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Genus Revenue, EBIT and net profit per share

DateGenus Sales per ShareGenus EBIT per shareGenus Earnings per Share
2029e11.39 undefined0 undefined1.36 undefined
2028e12.18 undefined0 undefined1.27 undefined
2027e11.4 undefined0 undefined1.04 undefined
2026e10.89 undefined0 undefined0.92 undefined
2025e10.48 undefined0 undefined0.79 undefined
202410.11 undefined0.82 undefined0.12 undefined
202310.45 undefined0.92 undefined0.5 undefined
20229.07 undefined0.87 undefined0.63 undefined
20218.75 undefined0.94 undefined0.72 undefined
20208.43 undefined0.7 undefined0.54 undefined
20197.48 undefined0.71 undefined0.12 undefined
20187.57 undefined0.69 undefined0.69 undefined
20177.42 undefined0.68 undefined0.53 undefined
20166.33 undefined0.64 undefined0.8 undefined
20156.48 undefined0.65 undefined0.65 undefined
20146.13 undefined0.72 undefined0.48 undefined
20135.66 undefined0.62 undefined0.44 undefined
20125.61 undefined0.29 undefined0.65 undefined
20115.11 undefined0.56 undefined0.48 undefined
20104.74 undefined0.55 undefined0.46 undefined
20094.68 undefined0.55 undefined0.3 undefined
20084.22 undefined0.42 undefined0.3 undefined
20074.14 undefined0.39 undefined0.26 undefined
20066.34 undefined0.3 undefined-0.01 undefined
20054.98 undefined0.26 undefined0.17 undefined

Genus business model

Genus PLC is a leading company in the animal breeding industry, offering innovative solutions for improving animal health and welfare. The company was founded in 1935 and is headquartered in the UK, operating worldwide in different countries. The business model of Genus PLC is based on the development, breeding, and marketing of livestock, particularly pigs and cattle. The company utilizes its extensive experience and expertise to promote the best traits in animals, helping breeders and farmers increase their production capacities and improve their yields. Genus PLC operates several business divisions, including Genus ABS, Genus PIC, and Genus Asia. Each of these divisions focuses on different animal species and geographical locations. The company also provides other services such as training and consultations for farmers. Genus ABS specializes in breeding dairy cattle. The products of Genus ABS are designed to achieve higher milk productivity while improving animal health and fertility. The services of Genus ABS also aim to enhance the profitability of the dairy industry. Genus PIC is a business division of Genus PLC specializing in pig breeding. The pig breeding products of Genus PIC are focused on achieving higher meat production while improving animal welfare. Additionally, Genus PIC offers services to support breeders and farmers. Genus Asia is a business division of Genus PLC operating in many Asian countries. The company specializes in improving the health and performance of livestock in Asian countries. The products and services of Genus Asia support breeders and farmers in increasing their profitability. Genus PLC also offers a wide range of products and services, including artificial insemination, estrus monitoring, feed additives, and nutritional supplements to improve the health and performance of livestock. The company also invests in research and innovation to develop new technologies and methods for improving animal health and breeding. Overall, Genus PLC is a leading company in the animal breeding industry, offering its customers innovative solutions to increase profitability and improve animal health. With its extensive experience and expertise, Genus PLC has a strong position in the industry and is committed to continuously improving its services and products to meet the needs of its customers. Genus is one of the most popular companies on Eulerpool.com.

Genus SWOT Analysis

Strengths

Genus PLC possesses several strengths that contribute to its competitive advantage. These strengths include:

  • Strong brand reputation and recognition in the industry
  • Wide portfolio of high-quality products and services
  • Well-established global presence and extensive distribution network
  • Robust research and development capabilities driving innovation
  • Experienced and skilled management team

Weaknesses

While Genus PLC has many strengths, there are also some weaknesses that may hinder its performance. These weaknesses include:

  • Reliance on a few key customers for a significant portion of its revenue
  • Potential vulnerability to economic downturns and fluctuations in the agriculture industry
  • Higher production costs compared to some competitors
  • Limited diversification across different product segments

Opportunities

Genus PLC can capitalize on various opportunities to further expand and enhance its business. These opportunities include:

  • Increasing global demand for high-quality animal genetics and reproduction technologies
  • Growing adoption of advanced genetic technologies in agriculture
  • Expansion into emerging markets with untapped potential
  • Potential collaborations and strategic partnerships to enhance market reach

Threats

However, Genus PLC also faces certain threats that could impact its operations and profitability. These threats include:

  • Intense competition from other global players in the market
  • Regulatory challenges and changing government policies affecting the agriculture sector
  • Fluctuating prices of agricultural commodities and raw materials
  • Risks associated with disease outbreaks and biosecurity concerns
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Genus Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Genus historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Genus shares outstanding

The number of shares was Genus in 2024 — This indicates how many shares 66.174 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Genus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Genus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Genus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Genus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Genus dividend history and estimates

In 2024, Genus paid a dividend amounting to 0.32 GBP. Dividend means that Genus distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Genus provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Genus’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Genus's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Genus Dividend History

DateGenus Dividend
2029e0.67 undefined
2028e0.63 undefined
2027e0.51 undefined
2026e0.45 undefined
2025e0.64 undefined
2024e0.64 undefined
2023e0.64 undefined
2025e0.32 undefined
2024e0.32 undefined
2023e0.32 undefined

Genus dividend payout ratio

In 2024, Genus had a payout ratio of 48.48%. The payout ratio indicates the percentage of the company's profits that Genus distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Genus represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Genus could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Genus's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Genus Payout Ratio History

DateGenus Payout ratio
2029e49.36 %
2028e49.48 %
2027e49.23 %
2026e49.38 %
2025e49.83 %
202448.48 %
202349.84 %
202251.17 %
202144.42 %
202053.94 %
2019231.99 %
201838.24 %
201744.49 %
201627.57 %
201533.38 %
201440.97 %
201340.66 %
201224.96 %
201130.79 %
201029.23 %
200940.74 %
200837.04 %
200740.44 %
2006-916.67 %
200549.02 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Genus.

Genus latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20190.4 0.43  (7.28 %)2020 Q2
6/30/20190.38 0.37  (-2.92 %)2019 Q4
12/31/20100.21 0.21  (1.46 %)2011 Q2
6/30/20100.17 0.19  (12.94 %)2010 Q4
6/30/20090.2 0.17  (-13.55 %)2009 Q4
12/31/20080.16 0.19  (17.5 %)2009 Q2
6/30/20080.17 0.16  (-5.68 %)2008 Q4
1

Eulerpool ESG Scorecard© for the Genus stock

Eulerpool World ESG Rating (EESG©)

72/ 100

🌱 Environment

67

👫 Social

86

🏛️ Governance

62

Environment

Scope 1 - Direct Emissions
66,977
Scope 2 - Indirect emissions from purchased energy
11,991
Scope 3 - Indirect emissions within the value chain
465,803
Total CO₂ emissions
78,968
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees35.1
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Genus shareholders

%
Name
Stocks
Change
Date
8.24736 % Baillie Gifford & Co.5,457,609309,68210/31/2024
6.48122 % abrdn Investment Management Limited4,288,88084,52910/31/2024
6.35348 % abrdn Investments Limited4,204,3513,605,2588/31/2024
5.71444 % Wellington Management Company, LLP3,781,47240,23010/31/2024
5.47740 % BlackRock Investment Management (UK) Ltd.3,624,61372,83210/31/2024
5.20959 % The Vanguard Group, Inc.3,447,39599,92510/31/2024
5.01447 % JNE Partners LLP3,318,2733,318,27312/10/2024
4.40241 % Devon Equity Management Ltd.2,913,248010/31/2024
4.34622 % Capital Research Global Investors2,876,066-11,38110/31/2024
3.92433 % Columbia Threadneedle Investments (UK)2,596,88808/31/2024
1
2
3
4
5
...
10

Genus Executives and Management Board

Mr. Jorgen Kokke

(55)
Genus Chief Executive Officer, Executive Director (since 2023)
Compensation 1.76 M

Ms. Alison Henriksen

Genus Chief Financial Officer, Executive Director (since 2020)
Compensation 949,000

Mr. Iain Ferguson

(68)
Genus Non-Executive Independent Chairman of the Board
Compensation 230,000

Prof. Jason Chin

Genus Non-Executive Independent Director
Compensation 75,000

Ms. Lysanne Gray

Genus Non-Executive Independent Director
Compensation 68,000
1
2
3

Genus Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Chr Hansen Holding Stock
Chr Hansen Holding
SupplierCustomer-0,53-0,77-0,85-0,140,48-0,19
1

Most common questions regarding Genus

What values and corporate philosophy does Genus represent?

Genus PLC represents a values-driven corporate philosophy focused on innovation, sustainability, and delivering value to stakeholders. The company prioritizes genetic improvement in animal breeding, aiming to enhance productivity and profitability for its customers. Genus PLC upholds high standards of animal welfare, ensuring healthy and sustainable food production. With a commitment to research and development, the company continually strives for advancements in its industry. Genus PLC emphasizes collaboration, integrity, and responsibility throughout its operations, fostering strong partnerships and maintaining a global presence. Through its dedication to excellence and ethical practices, Genus PLC consistently demonstrates its commitment to enhancing livestock genetics and driving positive change in the agricultural sector.

In which countries and regions is Genus primarily present?

Genus PLC is primarily present in various countries and regions worldwide. The company has a global presence, with key operations and business activities spanning across different continents. Genus PLC operates in North America, including the United States and Canada, where it has established significant market presence. Additionally, the company maintains a strong presence in Europe, with operations in countries such as the United Kingdom, Germany, France, and the Netherlands. Genus PLC also operates in key regions of Latin America, Asia-Pacific, and Africa, expanding its reach and serving customers in diverse markets around the globe.

What significant milestones has the company Genus achieved?

Genus PLC has achieved several significant milestones, solidifying its position as a leading biotechnology company. One of the notable accomplishments includes the successful launch of their proprietary genetic improvement technologies, which have revolutionized the livestock industry. Additionally, the company has expanded its global presence by establishing strategic partnerships and collaborations, enabling the development and delivery of innovative solutions to animal breeding challenges. Through continuous research and development efforts, Genus PLC has introduced groundbreaking genetic traits that enhance productivity, animal health, and welfare. Moreover, their commitment to sustainable development and responsible practices has earned them recognition in the industry. Genus PLC continues to drive advancements in animal genetics, contributing to the growth and success of the agricultural sector.

What is the history and background of the company Genus?

Genus PLC is a renowned company with a rich history and impressive background. Established in 1935, it has evolved into a global leader in animal genetic improvement. With a primary focus on breeding and biotechnology, Genus PLC constantly strives to enhance livestock productivity and quality through innovative genetic solutions. The company has a strong track record of delivering cutting-edge technologies and services, catering to the agricultural and food production sectors worldwide. Genus PLC's commitment to research and development, along with its unrivaled expertise, has solidified its position as a trusted partner for farmers and producers, revolutionizing the livestock industry.

Who are the main competitors of Genus in the market?

The main competitors of Genus PLC in the market include companies such as Neogen Corporation, Zoetis Inc., and Hendrix Genetics.

In which industries is Genus primarily active?

Genus PLC is primarily active in the animal genetics industry. With a solid reputation and global presence, the company specializes in animal breeding and genetics, facilitating improvements in livestock productivity and efficiency. Genus PLC's innovative solutions are widely utilized in various sectors, including cattle, pigs, and aquaculture. Leveraging cutting-edge biotechnology and extensive research, the company enables farmers and producers to enhance their animals' genetic potential, resulting in higher-quality products and increased profitability. Genus PLC's commitment to genetic advancement and technological expertise solidify its position as a leading player in the animal genetics industry.

What is the business model of Genus?

Genus PLC operates under a business model focused on animal genetics. As a leading global provider of innovative genetic solutions, Genus specializes in enhancing the productivity and sustainability of livestock farming. The company offers a wide range of products and services, including bovine and porcine genetic evaluation and improvement, as well as reproductive technologies. By leveraging cutting-edge genetic technologies, Genus aims to help livestock producers achieve improved profitability, efficiency, and sustainability. With a strong commitment to research and development, Genus continues to drive advancements in animal genetics, contributing to the overall growth and success of the industry.

What is the P/E ratio of Genus 2025?

The P/E ratio cannot be calculated for Genus at the moment.

What is the P/S ratio of Genus 2025?

The P/S cannot be calculated for Genus currently.

What is the Quality Investing of Genus?

The Quality Investing for Genus is 4/10.

What is the revenue of Genus 2025?

The expected Genus revenue is 693.62 M GBP.

How high is the profit of Genus 2025?

The expected Genus profit is 52.15 M GBP.

What is the business model of Genus

Genus PLC is a global leader in innovative animal breeding and genomics products. It operates in three core divisions: genetics, health, and agriculture. With a global network of customers, partners, and branches in over 70 countries, the company aims to utilize animal genetics for sustainable and profitable agriculture. The genetics division of Genus develops and supplies animal genetics for pigs and cattle to customers worldwide. The company utilizes advanced technologies and methods to develop innovative products that enhance growth characteristics, meat quality, feed efficiency, and milk production. Examples of products in the genetics division include the "PIC" pig genetics and the "ABS" cattle genetics, which have a strong market presence globally. The health division of Genus offers veterinary products and services for animal health. The company provides a wide range of vaccines, therapeutics, and medical services for livestock. One well-known product in this division is "PigSAFE," which is a program for improving biosecurity in pig farms. With the support of health services, animal health is protected and improved, resulting in better yields for breeders and farmers. The agriculture division of Genus aims to contribute to the sustainability, efficiency, and effectiveness of agriculture through innovative agricultural practices and technologies. The company supports customers worldwide in improving the productivity and profitability of farms. They utilize data and analysis to enable better decision-making and improve the efficiency of the value chain. Examples of products and services in this division include "Sexcel," an in-vitro fertilization services company, and "Strawman," an online auction platform for cattle semen. In summary, Genus PLC aims to offer innovative products and services for breeders and farmers to improve the efficiency, profitability, and sustainability of agriculture. With three core divisions - genetics, health, and agriculture - the company has a broad portfolio of products and services to support customers worldwide. The use of advanced technologies and methods helps secure the company's competitive advantage and make it a significant player in the agriculture and animal genomics industry. The answer is: Genus PLC is a global leader in innovative animal breeding and genomics products.

What is the Genus dividend?

Genus pays a dividend of 0.32 GBP distributed over payouts per year.

How often does Genus pay dividends?

The dividend cannot currently be calculated for Genus or the company does not pay out a dividend.

What is the Genus ISIN?

The ISIN of Genus is GB0002074580.

What is the Genus WKN?

The WKN of Genus is 762548.

What is the Genus ticker?

The ticker of Genus is GNS.L.

How much dividend does Genus pay?

Over the past 12 months, Genus paid a dividend of 0.32 GBP . This corresponds to a dividend yield of about . For the coming 12 months, Genus is expected to pay a dividend of 0.45 GBP.

What is the dividend yield of Genus?

The current dividend yield of Genus is .

When does Genus pay dividends?

Genus pays a quarterly dividend. This is distributed in the months of December, March, December, April.

How secure is the dividend of Genus?

Genus paid dividends every year for the past 7 years.

What is the dividend of Genus?

For the upcoming 12 months, dividends amounting to 0.45 GBP are expected. This corresponds to a dividend yield of 1.81 %.

In which sector is Genus located?

Genus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genus from 4/4/2025 amounting to 0.103 GBP, you needed to have the stock in your portfolio before the ex-date on 3/6/2025.

When did Genus pay the last dividend?

The last dividend was paid out on 4/4/2025.

What was the dividend of Genus in the year 2024?

In the year 2024, Genus distributed 0.32 GBP as dividends.

In which currency does Genus pay out the dividend?

The dividends of Genus are distributed in GBP.

All fundamentals about Genus

Our stock analysis for Genus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.